Screener
Recursion Pharmaceuticals, Inc. RXRX Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 89,623 | 103,931 |
| Operating lease right-of-use assets | 40,271 | 45,339 |
| Financing lease right-of-use assets | 17,179 | 20,210 |
| Intangible assets, net | 282,888 | 309,903 |
| Goodwill | 160,350 | 162,158 |
| Deferred tax assets | 957 | 957 |
| Other assets, non-current | 12,186 | 12,754 |
| Total assets | $1,212,668 | $1,474,130 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s intangibles (net)?
- Recursion Pharmaceuticals, Inc. (RXRX) reported intangibles (net) of $282.89M in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s intangibles (net) changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s intangibles (net) decreased by 17.1% year-over-year, from $341.32M to $282.89M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s intangibles (net)?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s intangibles (net) has grown at a 183.6% compound annual growth rate (CAGR), from $1.69M to $309.9M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Recursion Pharmaceuticals, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude